Entity Common Stock, Shares Outstanding of Immunovant, Inc. from 12 Jun 2019 to 02 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Immunovant, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Jun 2019 to 02 Feb 2026.
  • Immunovant, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 02 Feb 2026 was 203,532,180, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 203,532,180 +33,671,497 +20% 02 Feb 2026 10-Q 06 Feb 2026 2026 Q3
Q3 2025 175,276,526 +28,491,887 +19% 03 Nov 2025 10-Q 10 Nov 2025 2026 Q2
Q2 2025 174,316,841 +27,949,467 +19% 04 Aug 2025 10-Q 11 Aug 2025 2026 Q1
Q4 2024 169,860,683 +24,567,713 +17% 31 Jan 2025 10-Q 06 Feb 2025 2025 Q3
Q3 2024 146,784,639 +2,122,709 +1.5% 01 Nov 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 146,367,374 +15,695,707 +12% 30 Jul 2024 10-Q 06 Aug 2024 2025 Q1
Q4 2023 145,292,970 +15,047,635 +12% 05 Feb 2024 10-Q 12 Feb 2024 2024 Q3
Q3 2023 144,661,930 +15,479,479 +12% 03 Nov 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 130,671,667 +14,166,255 +12% 04 Aug 2023 10-Q 10 Aug 2023 2024 Q1
Q4 2022 130,245,335 +13,849,608 +12% 27 Jan 2023 10-Q 03 Feb 2023 2023 Q3
Q3 2022 129,182,451 +14,182,205 +12% 28 Oct 2022 10-Q 04 Nov 2022 2023 Q2
Q2 2022 116,505,412 +18,528,717 +19% 03 Jun 2022 10-K 08 Jun 2022 2022 FY
Q4 2021 116,395,727 01 Feb 2022 10-Q 04 Feb 2022 2022 Q3
Q3 2021 115,000,246 +17,109,541 +17% 01 Nov 2021 10-Q 05 Nov 2021 2021 Q2
Q2 2021 97,976,695 +16,164,968 +20% 01 Jun 2021 10-K 01 Jun 2021 2020 FY
Q1 2021 97,971,243 16 Feb 2021 10-Q 16 Feb 2021 2021 Q3
Q3 2020 97,890,705 +83,515,705 +581% 12 Nov 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 81,811,727 +67,436,727 +469% 29 Jun 2020 10-K 29 Jun 2020 2019 FY
Q4 2019 56,455,376 14 Feb 2020 10-Q 14 Feb 2020 2019 Q3
Q3 2019 14,375,000 13 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 14,375,000 12 Jun 2019 10-Q 12 Jun 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.